Sangamo Therapeutics
SGMO
#8725
Rank
ยฃ0.12 B
Marketcap
ยฃ0.37
Share price
-6.45%
Change (1 day)
-76.41%
Change (1 year)

Revenue for Sangamo Therapeutics (SGMO)

Revenue in 2025 (TTM): ยฃ24.76 Million

According to Sangamo Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ24.65 Million. In 2024 the company made a revenue of ยฃ46.05 Million a decrease over the revenue in the year 2023 that were of ยฃ0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sangamo Therapeutics from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ24.76 M-46.24%
2024 ยฃ46.05 M-66.7%
2023 ยฃ0.13 B50.36%
2022 ยฃ91.99 M12.18%
2021 ยฃ82.01 M-5.42%
2020 ยฃ86.71 M11.01%
2019 ยฃ78.11 M17.41%
2018 ยฃ66.53 M145.9%
2017 ยฃ27.05 M72.19%
2016 ยฃ15.71 M-41.11%
2015 ยฃ26.68 M-9.44%
2014 ยฃ29.46 M101.38%
2013 ยฃ14.63 M9.2%
2012 ยฃ13.39 M101.81%
2011 ยฃ6.63 M-50.74%
2010 ยฃ13.47 M-1.7%
2009 ยฃ13.71 M24.15%
2008 ยฃ11.04 M141.15%
2007 ยฃ4.57 M13.77%
2006 ยฃ4.02 M179.57%
2005 ยฃ1.43 M110.21%
2004 ยฃ0.68 M-52.49%
2003 ยฃ1.44 M-46.77%
2002 ยฃ2.7 M-19.61%
2001 ยฃ3.36 M46.48%
2000 ยฃ2.3 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Gilead Sciences
GILD
ยฃ21.81 B 88,374.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ2.40 B 9,664.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ26.98 B 109,317.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ7.55 B 30,518.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
ยฃ30.68 B 124,350.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 B 280,201.14%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ2.32 B 9,311.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.18 B 195,291.63%๐Ÿ‡บ๐Ÿ‡ธ USA